IL17A and Hepatitis: Compelling evidence indicates that utilizing an induced hepatitis model in mice to ameliorate liver damage, as seen by a reduction in inflammatory cytokines Institute for functional nanomaterials (IFN-γ), interleukin-6 (IL-6), interleukin-17 (IL-17), and serum alanine aminotransferase (141, 142).